{'fraction_non_alphanumeric': 0.05173427395649618, 'fraction_numerical': 0.042915931804820694, 'mean_word_length': 4.769491525423729, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
EVALUATION OF EFFICACY OF DIFFERENT METHODS FOR MICROBIAL ECZEMA TREATMENT

The aim of the study is to analyze the effectiveness of the methods of treatment (MT) of microbial eczema (ME) available in pediatric practice. Materials and methods of research: the article presents the results of the evaluation of efficacy of the methods of treatment of ME in 108 patients aged 1–13 years with ME, taking into account the study of their safety and financial feasibility. ME severity was assessed using IOSTME (Microbial Eczema Severity Evaluation Index). The efficacy of ME therapy was assessed using clinical criteria. Results: with the same safety and clinical efficacy, the use of cold atmospheric plasma (CAP) in the complex therapy of ME has an advantage over the standard treatment method (MT1) and over complex therapy using laser therapy (MT2). The health care efficiency (Km) differed in the use of analytic treatments with the highest proportion of clinical recovery results (complete skin cleansing) in patients receiving complex therapy using CAP (MT3): when using MT1 – in 1 out of 20 cases (5%), with MT2 – in 3 out of 49 patients (6%), with MT3 – in 26 out of 39 cases (67%) (p<0,001). The decrease in the cost of complex treatment methods (MT2 and MT3) was due to a significant reduction in the duration of inpatient treatment: when using MT1 – 14,5 [14,0; 15,0], MT2 – 11,0 [10,0; 12,0], MT3 – 6,0 [6,0; 6,0] bed-days, despite the more expensive medical services for MT2 (1,37 times more expensive than MT1) and MT3 (2,33 times more expensive than MT1 and 1,71 times more expensive than MT2). Conclusion: the use of CAP in the complex treatment of ME is effective, safe and cost-effective.